Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018

SELL
$4.64 - $7.11 $1,067 - $1,635
-230 Closed
0 $0
Q2 2018

Aug 07, 2018

BUY
$6.29 - $8.22 $1,446 - $1,890
230 New
230 $2,000
Q1 2018

May 14, 2018

SELL
$6.51 - $9.14 $1,497 - $2,102
-230 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$7.74 - $10.78 $1,780 - $2,479
230
230 $2,000

Others Institutions Holding ORMP

About ORAMED PHARMACEUTICALS INC.


  • Ticker ORMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,100
  • Market Cap $92M
  • Description
  • Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...
More about ORMP
Track This Portfolio

Track Landaas & CO Portfolio

Follow Landaas & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Landaas & CO , based on Form 13F filings with the SEC.

News

Stay updated on Landaas & CO with notifications on news.